Latest News in Cancer
Stay updated with the most recent articles and resources.
Main Topics
An Informative Guide On The Signs And Symptoms Of Multiple Myeloma
Read our guide to learn about the silent indicators of multiple myeloma. Learn to spot them early, so you can make smart choices for your...
A Closer Look At The Various Stages Of Multiple Myeloma
Learn about the different stages and types of multiple myeloma. Find hope and support with information on treatments and coping strategies. This simple guide can...
How Does Diagnostic Imaging Save Lives in Multiple Myeloma Battles?
Curious about how a medical technique is saving the lives of multiple myeloma patients? Read our blog to learn more about this life-saving technique! Let’s...
The Key To CAR-T Success Lies In Patient Selection: Are You The Ideal One?
Discover the magic of CAR-T treatment! Read our blog on patient selection for CAR T therapy. Are you the ideal candidate for this innovative cancer...
Immunotherapy Can Help You Win the Battle Against Multiple Myeloma!
Discover how immunotherapy can be your true friend in beating myeloma! Our blog provides simple insights into the power of immunotherapy for multiple myeloma. Don’t...
How Stem Cell Transplant Is Reshaping The Future Of Multiple Myeloma Treatment?
Stem cell transplantation is an effective treatment for multiple myeloma, a type of blood cancer. This procedure has shown promising results in improving the lives...
CAR T Cells Are Reshaping the Future of Cancer Treatment!
The revolutionary CAR T Cell Therapy is changing the scenario of how we deal with cancer, making it more personal and powerful. This latest therapy...
The Role Of Immunotherapy In Lymphoma Treatment
If you’re reading this, you or maybe one of your loved ones is on a journey that no one ever plans to take—the path of...
Ivosidenib is approved by FDA for myelodysplastic syndromes
The Food and Drug Administration approved ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) for adult patients with relapsed or refractory myelodysplastic syndromes (MDS) with a susceptible isocitrate...
Neoadjuvant/ adjuvant pembrolizumab is approved by the FDA for resectable non-small cell lung cancer
The Food and Drug Administration approved pembrolizumab (Keytruda, Merck) with platinum-containing chemotherapy as neoadjuvant treatment, and with continuation of single-agent pembrolizumab as post-surgical adjuvant treatment...
Nivolumab is approved by the FDA for adjuvant treatment of Stage IIB/C melanoma
The Food and Drug Administration approved nivolumab (Opdivo, Bristol-Myers Squibb Company) for the adjuvant treatment of completely resected Stage IIB/C melanoma in patients 12 years...
Encorafenib with binimetinib is approved by the FDA for treatment of metastatic non-small cell lung cancer with a BRAF V600E mutation
The Food and Drug Administration approved encorafenib (Braftovi, Array BioPharma Inc., a wholly owned subsidiary of Pfizer) with binimetinib (Mektovi, Array BioPharma Inc.) for adult...
Need help? Our team is ready to assist you.
We wish a speedy recovery for your loved ones.